Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	nuclear retinoic acid receptor binding	PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	7.49e-05	55	258	6	GO:0042974
GeneOntologyMolecularFunction	ubiquitin-like ligase-substrate adaptor activity	PRAMEF9 PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	9.23e-05	82	258	7	GO:1990756
GeneOntologyMolecularFunction	metal ion transmembrane transporter activity	SLC17A2 PKD1L1 SLC30A4 RYR3 NALCN ATP2C2 PKD1 SLC9A7 KCNQ3 GRIN3A CACNA2D1 HCN4 HCN1 GRIN1 SLC5A11 SLC9A1 SLC30A5	1.24e-04	465	258	17	GO:0046873
GeneOntologyMolecularFunction	olfactory receptor activity	OR2M2 OR7A5 OR6K2 OR2W1 OR2M5 OR2M3 OR52B4 OR2Z1 OR4D5 OR56B4 OR8I2 OR6K6 OR4K14 OR51V1 GPR148 OR2A2	1.65e-04	431	258	16	GO:0004984
GeneOntologyMolecularFunction	enzyme-substrate adaptor activity	PRAMEF9 PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	2.33e-04	95	258	7	GO:0140767
GeneOntologyBiologicalProcess	prepulse inhibition	BACE1 FABP7 NRXN1 GRIN3A GRIN1	3.92e-06	20	258	5	GO:0060134
GeneOntologyBiologicalProcess	startle response	BACE1 FABP7 NRXN1 GRIN3A SLITRK6 GRIN1	1.13e-05	41	258	6	GO:0001964
GeneOntologyCellularComponent	Cul2-RING ubiquitin ligase complex	PRAMEF9 PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 GLMN PRAMEF27	1.03e-07	47	259	8	GO:0031462
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH10 DNAH1	2.12e-04	10	259	3	GO:0036156
GeneOntologyCellularComponent	axonemal dynein complex	CFAP70 DNHD1 DNAH10 DNAH1	2.37e-04	25	259	4	GO:0005858
GeneOntologyCellularComponent	Golgi membrane	MBTPS1 ATP6AP1 MAN1A1 MAN2A1 QPCTL SAMD8 COPE CHST15 ATP2C2 PKD1 SLC9A7 ST8SIA5 RIC1 TPST1 COPG1 COPG2 PGAP4 CD1E SLC30A5 SORL1 RAB11FIP3	2.71e-04	721	259	21	GO:0000139
GeneOntologyCellularComponent	cullin-RING ubiquitin ligase complex	PRAMEF9 KLHL42 PRAMEF26 PRAMEF11 USP47 PRAMEF15 PRAMEF12 PRAMEF4 GLMN PRAMEF27	3.28e-04	212	259	10	GO:0031461
GeneOntologyCellularComponent	COPI vesicle coat	COPE COPG1 COPG2	4.90e-04	13	259	3	GO:0030126
Domain	PRAME_family	PRAMEF25 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	4.62e-06	19	256	5	IPR026271
Domain	PSI	PLXNB2 PLXNB1 SEMA3C MST1R MEGF8 PLXDC2	2.85e-05	44	256	6	IPR016201
Domain	PSI	PLXNB2 PLXNB1 SEMA3C MST1R MEGF8 PLXDC2	3.70e-05	46	256	6	SM00423
Domain	Plexin_repeat	PLXNB2 PLXNB1 MST1R MEGF8 PLXDC2	6.92e-05	32	256	5	IPR002165
Domain	PSI	PLXNB2 PLXNB1 MST1R MEGF8 PLXDC2	6.92e-05	32	256	5	PF01437
Domain	Coatomer/calthrin_app_sub_C	COPG1 COPG2 AP4E1	1.35e-04	8	256	3	IPR009028
Domain	Coatomer_g_Cpla	COPG1 COPG2	1.87e-04	2	256	2	IPR032154
Domain	AMMECR1_domain	AMMECR1L AMMECR1	1.87e-04	2	256	2	IPR002733
Domain	Coatomer_gsu_app_Ig-like-sub	COPG1 COPG2	1.87e-04	2	256	2	IPR013040
Domain	-	AMMECR1L AMMECR1	1.87e-04	2	256	2	3.30.700.20
Domain	AMMECR1	AMMECR1L AMMECR1	1.87e-04	2	256	2	IPR023473
Domain	-	COPG1 COPG2	1.87e-04	2	256	2	2.60.40.1480
Domain	RBM39_linker	RBM23 RBM39	1.87e-04	2	256	2	IPR029123
Domain	AMMECR1_N	AMMECR1L AMMECR1	1.87e-04	2	256	2	IPR027485
Domain	COP-gamma_platf	COPG1 COPG2	1.87e-04	2	256	2	PF08752
Domain	RBM39_SF	RBM23 RBM39	1.87e-04	2	256	2	IPR006509
Domain	Coatomer_g_Cpla	COPG1 COPG2	1.87e-04	2	256	2	PF16381
Domain	AMMECR1	AMMECR1L AMMECR1	1.87e-04	2	256	2	PF01871
Domain	AMMECR1	AMMECR1L AMMECR1	1.87e-04	2	256	2	PS51112
Domain	Coatomer_gsu	COPG1 COPG2	1.87e-04	2	256	2	IPR017106
Domain	RBM39linker	RBM23 RBM39	1.87e-04	2	256	2	PF15519
Domain	ARM-type_fold	USP34 GPRASP1 ATR RYR3 NBEAL2 EIF2B5 UTP20 COPG1 UBR4 COPG2 AP4E1 CNOT9 CTNND2 TNPO3	2.58e-04	339	256	14	IPR016024
Domain	Olfact_rcpt	OR2M2 OR7A5 OR6K2 OR2W1 OR2M5 OR2M3 OR52B4 OR2Z1 OR4D5 OR56B4 OR8I2 OR6K6 OR4K14 OR51V1 OR2A2	3.63e-04	393	256	15	IPR000725
Domain	EGF_LAM_2	HSPG2 LAMA2 LAMA4 MEGF8	7.14e-04	30	256	4	PS50027
Domain	EGF_LAM_1	HSPG2 LAMA2 LAMA4 MEGF8	7.14e-04	30	256	4	PS01248
Domain	SEMA	PLXNB2 PLXNB1 SEMA3C MST1R	8.11e-04	31	256	4	PS51004
Domain	Semap_dom	PLXNB2 PLXNB1 SEMA3C MST1R	8.11e-04	31	256	4	IPR001627
Domain	TIG	PLXNB2 CAMTA1 PLXNB1 MST1R	8.11e-04	31	256	4	PF01833
Domain	Sema	PLXNB2 PLXNB1 SEMA3C MST1R	8.11e-04	31	256	4	SM00630
Domain	Sema	PLXNB2 PLXNB1 SEMA3C MST1R	8.11e-04	31	256	4	PF01403
Domain	MT	DNHD1 DNAH10 DNAH1	8.28e-04	14	256	3	PF12777
Domain	Dynein_HC_stalk	DNHD1 DNAH10 DNAH1	8.28e-04	14	256	3	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH10 DNAH1	8.28e-04	14	256	3	IPR013602
Domain	DHC_N2	DNHD1 DNAH10 DNAH1	8.28e-04	14	256	3	PF08393
Domain	IPT	PLXNB2 CAMTA1 PLXNB1 MST1R	9.17e-04	32	256	4	IPR002909
Domain	VWFA	ITGAL CPNE1 VWA3A CACNA2D1 COL12A1 VWA1	9.17e-04	82	256	6	PS50234
Domain	VWA	ITGAL VWA3A CACNA2D1 COL12A1 VWA1	1.01e-03	56	256	5	PF00092
Domain	Adaptin_N	COPG1 COPG2 AP4E1	1.03e-03	15	256	3	PF01602
Domain	DHC_fam	DNHD1 DNAH10 DNAH1	1.03e-03	15	256	3	IPR026983
Domain	Clathrin/coatomer_adapt-like_N	COPG1 COPG2 AP4E1	1.03e-03	15	256	3	IPR002553
Domain	Dynein_heavy	DNHD1 DNAH10 DNAH1	1.03e-03	15	256	3	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH10 DNAH1	1.03e-03	15	256	3	IPR004273
Domain	VWA	ITGAL CPNE1 VWA3A CACNA2D1 COL12A1 VWA1	1.04e-03	84	256	6	SM00327
Domain	Pecanex_C	PCNX3 PCNX1	1.10e-03	4	256	2	PF05041
Domain	-	COPG1 COPG2	1.10e-03	4	256	2	3.30.310.30
Domain	Ion_trans_N	HCN4 HCN1	1.10e-03	4	256	2	IPR013621
Domain	Clathrin_a/coatomer_app_sub_C	COPG1 COPG2	1.10e-03	4	256	2	IPR015873
Domain	Ion_trans_N	HCN4 HCN1	1.10e-03	4	256	2	PF08412
Domain	REJ	PKD1L1 PKD1	1.10e-03	4	256	2	PS51111
Domain	Pecanex	PCNX3 PCNX1	1.10e-03	4	256	2	IPR007735
Domain	REJ_dom	PKD1L1 PKD1	1.10e-03	4	256	2	IPR014010
Domain	Laminin_G	NRXN1 HSPG2 COL12A1 LAMA2 LAMA4	1.18e-03	58	256	5	IPR001791
Domain	cNMP-bd_CS	HCN4 HCN1 PRKG1	1.25e-03	16	256	3	IPR018488
Domain	EGF_Lam	HSPG2 LAMA2 LAMA4 MEGF8	1.29e-03	35	256	4	SM00180
Domain	Laminin_EGF	HSPG2 LAMA2 LAMA4 MEGF8	1.29e-03	35	256	4	PF00053
Domain	LAM_G_DOMAIN	NRXN1 HSPG2 LAMA2 LAMA4	1.76e-03	38	256	4	PS50025
Domain	Laminin_EGF	HSPG2 LAMA2 LAMA4 MEGF8	1.76e-03	38	256	4	IPR002049
Domain	Nucleotide_cyclase	ADCY10 GUCY1A2 GUCY2C	1.78e-03	18	256	3	IPR029787
Domain	LH2	PKD1L1 PKD1 LIPC	1.78e-03	18	256	3	SM00308
Domain	-	ADCY10 GUCY1A2 GUCY2C	1.78e-03	18	256	3	3.30.70.1230
Domain	RasGAP_dom	PLXNB2 RASA4B PLXNB1	1.78e-03	18	256	3	IPR001936
Domain	Laminin_domII	LAMA2 LAMA4	1.82e-03	5	256	2	IPR010307
Domain	Laminin_aI	LAMA2 LAMA4	1.82e-03	5	256	2	IPR009254
Domain	Laminin_I	LAMA2 LAMA4	1.82e-03	5	256	2	PF06008
Domain	Laminin_II	LAMA2 LAMA4	1.82e-03	5	256	2	PF06009
Domain	Guanylate_cyc	ADCY10 GUCY1A2 GUCY2C	2.10e-03	19	256	3	PF00211
Domain	GUANYLATE_CYCLASE_2	ADCY10 GUCY1A2 GUCY2C	2.10e-03	19	256	3	PS50125
Domain	A/G_cyclase	ADCY10 GUCY1A2 GUCY2C	2.10e-03	19	256	3	IPR001054
Domain	CYCc	ADCY10 GUCY1A2 GUCY2C	2.10e-03	19	256	3	SM00044
Domain	GUANYLATE_CYCLASE_1	ADCY10 GUCY1A2 GUCY2C	2.10e-03	19	256	3	PS00452
Domain	Laminin_G_2	NRXN1 HSPG2 LAMA2 LAMA4	2.14e-03	40	256	4	PF02210
Pubmed	Sertoli cell-only phenotype and scRNA-seq define PRAMEF12 as a factor essential for spermatogenesis in mice.	PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	1.11e-08	22	260	6	31729367
Pubmed	MAGE-B4, a binding partner of PRAMEF12, is dispensable for spermatogenesis and male fertility in mice.	PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	2.59e-08	25	260	6	37451217
Pubmed	Differences in gene expression between mouse and human for dynamically regulated genes in early embryo.	PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	5.41e-08	28	260	6	25089626
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	USP34 MBTPS1 EMC3 ATP6AP1 MAN1A1 MAN2A1 QPCTL ATR COPE PLXNB2 LRP1B UTP20 PLXNB1 HSPG2 TPST1 CACNA2D1 SEMA3C COL12A1 LAMA4 PGAP4 SELENON MST1R MEGF8 FANCI LOXL2 SCARB1 MSLN SORL1	1.22e-07	1201	260	28	35696571
Pubmed	Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.	PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	2.23e-07	35	260	6	19389355
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 PCNX3 TRIO MYO10 SLC35E2B PLXNB2 CHST15 NBEAL2 PKD1 ABCD1 PPP2R3C UVRAG TRAPPC9 RIC1 HSPG2 MARVELD1 UBR4 PIP5K1C DHX30 MST1R MEGF8 FANCI SCARB1 PCNX1 TNPO3 RAB11FIP3	2.98e-07	1105	260	26	35748872
Pubmed	Preferentially Expressed Antigen in Melanoma (PRAME) and the PRAME Family of Leucine-Rich Repeat Proteins.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	3.18e-07	20	260	5	26694250
Pubmed	A unified nomenclature for vertebrate olfactory receptors.	OR2M2 OR7A5 OR6K2 OR2W1 OR2M5 OR2M3 OR52B4 OR2Z1 OR4D5 OR56B4 OR8I2 OR6K6 OR51V1 OR2A2	3.70e-07	343	260	14	32295537
Pubmed	Odorant receptor expressed sequence tags demonstrate olfactory expression of over 400 genes, extensive alternate splicing and unequal expression levels.	OR2M2 OR7A5 OR6K2 OR2W1 OR2M5 OR2M3 OR52B4 OR2Z1 OR4D5 OR56B4 OR8I2 OR6K6 OR51V1 OR2A2	4.11e-07	346	260	14	14611657
Pubmed	Calcineurin Inhibition Causes α2δ-1-Mediated Tonic Activation of Synaptic NMDA Receptors and Pain Hypersensitivity.	CACNA2D1 GRIN1 AVIL	4.13e-07	3	260	3	32269108
Pubmed	α2δ-1 Upregulation in Primary Sensory Neurons Promotes NMDA Receptor-Mediated Glutamatergic Input in Resiniferatoxin-Induced Neuropathy.	CACNA2D1 GRIN1 AVIL	4.13e-07	3	260	3	34252037
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	HK2 ATR RCC2 FAM111B SLC25A32 EIF2B5 STARD3 PZP PLXNB1 RIC1 PMS1 CDC42BPG SEMA3C EML4 SLC30A5 DOCK7 EIF2AK4 PATJ SORL1	5.47e-07	650	260	19	38777146
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	USP34 ZNF274 IREB2 ZNF112 PRAMEF11 HSPG2 COL12A1 PRAMEF15 PRAMEF12 PRAMEF4 LRIG1 NACC2 FANCI CDK5RAP2	7.28e-07	363	260	14	14691545
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	MYO10 STIMATE SPTBN1 PLXNB2 INTS2 NBEAL2 WNT16 ABCD1 FHIP1A TRAPPC9 PRAMEF11 VWA3A COPG1 PRAMEF15 PRAMEF12 GRIN1 PRAMEF4 PIP5K1C SELENON CAPN11 AP4E1 LRIG1 NACC2 CNOT9 FANCI CDK5RAP2 RAPGEFL1	8.08e-07	1242	260	27	30973865
Pubmed	Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3.	HK2 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	1.30e-06	26	260	5	18500982
Pubmed	High-throughput microarray detection of olfactory receptor gene expression in the mouse.	OR2M2 OR2M5 OR2M3	1.64e-06	4	260	3	15377787
Pubmed	Different evolutionary processes shaped the mouse and human olfactory receptor gene families.	OR2M2 OR7A5 OR6K2 OR2W1 OR2M5 OR2M3 OR52B4 OR2Z1 OR4D5 OR56B4 OR8I2 OR51V1 OR2A2	2.00e-06	340	260	13	11875048
Pubmed	The olfactory receptor gene superfamily of the mouse.	OR2M2 OR7A5 OR6K2 OR2W1 OR2M5 OR2M3 OR52B4 OR2Z1 OR4D5 OR56B4 OR8I2 OR51V1 OR2A2	2.00e-06	340	260	13	11802173
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	MBTPS1 TRIO ATP9B SLC30A4 SESN1 HNRNPL ASAP2 INTS2 SLC9A7 CAMTA1 PRKAG2 TRAPPC9 RIC1 ADSS1 CDC42BPG TIGAR SELENON CREBBP RBM39 DNAH1 PLXDC2 NACC2 LOXL2 SCARB1 ASS1 EIF2AK4 GREB1 PATJ PCCA	2.76e-06	1489	260	29	28611215
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	ATXN2L TRIO SPTBN1 RCC2 HNRNPL PHKA1 PZP PHIP TRAPPC9 CACNA2D1 EXOSC10 UBR4 PIP5K1C RBM39 DHX30	3.47e-06	475	260	15	31040226
Pubmed	GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles.	COPE TPST1 COPG1 COPG2 PGAP4	3.84e-06	32	260	5	34473204
Pubmed	Interplay between scatter factor receptors and B plexins controls invasive growth.	PLXNB2 PLXNB1 MST1R	4.08e-06	5	260	3	15184888
Pubmed	TGFβ attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination.	SPTBN1 ERAP2 ABCD1 TRHDE HSPG2 MST1R LOXL2 SCARB1 SORL1	4.39e-06	164	260	9	32409323
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	PLXNB2 FREM1 HSPG2 SEMA3C COL12A1 LAMA2 LAMA4 VWA1 PLXDC2	5.08e-06	167	260	9	22159717
Pubmed	Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	6.73e-06	17	260	4	23565261
Pubmed	Mouse Pramel1 regulates spermatogonial development by inhibiting retinoic acid signaling during spermatogenesis.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	6.73e-06	17	260	4	37781892
Pubmed	Brief Opioid Exposure Paradoxically Augments Primary Afferent Input to Spinal Excitatory Neurons via α2δ-1-Dependent Presynaptic NMDA Receptors.	CACNA2D1 GRIN1 AVIL	8.12e-06	6	260	3	36379705
Pubmed	Theta-Burst Stimulation of Primary Afferents Drives Long-Term Potentiation in the Spinal Cord and Persistent Pain via α2δ-1-Bound NMDA Receptors.	CACNA2D1 GRIN1 AVIL	8.12e-06	6	260	3	34880118
Pubmed	Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	8.60e-06	18	260	4	39181896
Pubmed	Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	8.60e-06	18	260	4	29731491
Pubmed	Identification of a new expanding family of genes characterized by atypical LRR domains. Localization of a cluster preferentially expressed in oocyte.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	8.60e-06	18	260	4	14675769
Pubmed	The promoter of the oocyte-specific gene, Oog1, functions in both male and female meiotic germ cells in transgenic mice.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	8.60e-06	18	260	4	23894331
Pubmed	Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	8.60e-06	18	260	4	12890732
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	ATP6AP1 MAN1A1 MAN2A1 SPTBN1 ACSM1 HNRNPL PKD1 CFAP70 PLEKHA7 DNHD1 HSPG2 CACNA2D1 ANKFY1 NIBAN2 TSPAN1 SLC4A1 MEGF8 ATP6V0A4 ASS1 CDK5RAP2 PATJ SORL1	9.41e-06	1016	260	22	19056867
Pubmed	Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	1.08e-05	19	260	4	28604677
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	ATP6AP1 QPCTL COPE SPTBN1 HNRNPL INTS2 EIF2B5 CPNE1 CERS2 SEMA3C COPG1 UBR4 COPG2 GLMN FANCI PCNX1 TNPO3	1.09e-05	657	260	17	36180527
Pubmed	Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	1.35e-05	20	260	4	21425410
Pubmed	Oog1, an oocyte-specific protein, interacts with Ras and Ras-signaling proteins during early embryogenesis.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	1.35e-05	20	260	4	16580637
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	USP34 NRXN1 CHST15 NBEAL2 PIP5K1C ZNF451 GREB1	1.47e-05	105	260	7	9628581
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	USP34 TRAF1 ATR TRIO ACVR1 ACVR1B RCC2 PHKA1 INTS2 PRKAG2 KLHL6 ANKFY1 EML4 POLR2H CREBBP GEMIN7 MAPK14 CDK5RAP2 EIF2AK4 PRKG1	1.96e-05	910	260	20	36736316
Pubmed	In vivo assembly of coatomer, the COP-I coat precursor.	COPE COPG1 COPG2	2.25e-05	8	260	3	8940050
Pubmed	Oogenesis specific genes (Nobox, Oct4, Bmp15, Gdf9, Oogenesin1 and Oogenesin2) are differentially expressed during natural and gonadotropin-induced mouse follicular development.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	2.42e-05	23	260	4	19480014
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 SPTBN1 MFSD14A AMMECR1L INTS2 HPS1 CAMTA1 PLEKHA7 PLXNB1 PRAMEF11 KLHL6 CERS2 SHLD2 EXOSC10 PRAMEF15 COPG2 PRAMEF12 PRAMEF4 CDK5RAP2 EIF2AK4 PATJ RAB11FIP3	2.53e-05	1084	260	22	11544199
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	MAN2A1 PZP PLXNB1 GPLD1 HSPG2 CACNA2D1 LAMA2 MEGF8 PLXDC2 TNXB	2.65e-05	257	260	10	16335952
Pubmed	A single binding site for dilysine retrieval motifs and p23 within the gamma subunit of coatomer.	COPE COPG1 COPG2	3.36e-05	9	260	3	9751720
Pubmed	COP I domains required for coatomer integrity, and novel interactions with ARF and ARF-GAP.	COPE COPG1 COPG2	3.36e-05	9	260	3	10921873
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP34 EMC3 HK2 COPE SPTBN1 RCC2 PGM3 HNRNPL EIF2B5 IFI44L HCFC2 TRAPPC9 CERS2 CACNA2D1 EXOSC10 COPG1 UBR4 COPG2 PGAP4 RBM39 GLMN CNOT9 FANCI DOCK7 MRPS33 TNPO3	3.39e-05	1440	260	26	30833792
Pubmed	Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	3.41e-05	25	260	4	12620990
Pubmed	A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication.	MYOM1 OR2W1 ATP9B NRXN1 PKD1 AMMECR1 GPLD1 UBR4 SLC4A1	4.24e-05	218	260	9	19460752
Pubmed	Comprehensive proteomic characterization of stem cell-derived extracellular matrices.	PZP HSPG2 COL12A1 VWA1 LOXL2 TNXB	4.70e-05	86	260	6	28327460
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	HECW1 MYO10 MATK IREB2 HPS1 GRIN3A HEPHL1 PZP TRAPPC9 PMS1 CACNA2D1 CREBBP SLC4A1 LIPC GUCY1A2 GREB1 PRKG1 PATJ	4.75e-05	814	260	18	23251661
Pubmed	A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints.	USP34 ATR FANCI	4.77e-05	10	260	3	17478428
Pubmed	Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses.	MAN1A1 MAN2A1 GANC	4.77e-05	10	260	3	18314154
Pubmed	HIV-1 gp120 N-linked glycosylation differs between plasma and leukocyte compartments.	MAN1A1 MAN2A1 GANC	4.77e-05	10	260	3	18215327
Pubmed	Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility.	MAN1A1 MAN2A1 GANC	4.77e-05	10	260	3	18330979
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	PLXNB2 HSPG2 COL12A1 LAMA2 LAMA4 VWA1 LOXL2 TNXB	5.55e-05	175	260	8	28071719
Pubmed	Social stress profoundly affects lipid metabolism: over-expression of SR-BI in liver and changes in lipids and lipases in plasma and tissues of stressed mice.	LIPC SCARB1	5.57e-05	2	260	2	17222414
Pubmed	Glial pathology in a novel spontaneous mutant mouse of the Eif2b5 gene: a vanishing white matter disease model.	FABP7 EIF2B5	5.57e-05	2	260	2	31587290
Pubmed	Further insights into the spectrum phenotype of TRAPPC9 and CDK5RAP2 genes, segregating independently in a large Tunisian family with intellectual disability and microcephaly.	TRAPPC9 CDK5RAP2	5.57e-05	2	260	2	34737153
Pubmed	Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.	ATR MAPK14	5.57e-05	2	260	2	34969765
Pubmed	Functional regulation of semaphorin receptors by proprotein convertases.	PLXNB2 PLXNB1	5.57e-05	2	260	2	12533544
Pubmed	Membrane domain organization of myelinated axons requires βII spectrin.	SPTBN1 AVIL	5.57e-05	2	260	2	24217619
Pubmed	Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A.	GRIN3A GRIN1	5.57e-05	2	260	2	9620802
Pubmed	RhoGEF17, a Rho-specific guanine nucleotide exchange factor activated by phosphorylation via cyclic GMP-dependent kinase Iα.	ARHGEF17 PRKG1	5.57e-05	2	260	2	23195829
Pubmed	Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization.	SLC9A1 MAPK14	5.57e-05	2	260	2	11604491
Pubmed	Genomic organization of a mouse type I activin receptor.	ACVR1 ACVR1B	5.57e-05	2	260	2	7639738
Pubmed	Supralinear potentiation of NR1/NR3A excitatory glycine receptors by Zn2+ and NR1 antagonist.	GRIN3A GRIN1	5.57e-05	2	260	2	18711142
Pubmed	Isolation and expression of murine and rabbit cDNAs encoding an alpha 1,2-mannosidase involved in the processing of asparagine-linked oligosaccharides.	MAN1A1 MAN2A1	5.57e-05	2	260	2	8144580
Pubmed	Coordinate control of axon defasciculation and myelination by laminin-2 and -8.	LAMA2 LAMA4	5.57e-05	2	260	2	15699217
Pubmed	N-methyl-D-aspartate receptor subunit NR3A in the retina: developmental expression, cellular localization, and functional aspects.	GRIN3A GRIN1	5.57e-05	2	260	2	14507892
Pubmed	Molecular composition and functional properties of f-channels in murine embryonic stem cell-derived pacemaker cells.	HCN4 HCN1	5.57e-05	2	260	2	19135060
Pubmed	Chromosomal localization of three human genes encoding members of the TGF-beta superfamily of type I serine/threonine kinase receptors.	ACVR1 ACVR1B	5.57e-05	2	260	2	9501322
Pubmed	Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors.	GRIN3A GRIN1	5.57e-05	2	260	2	31444392
Pubmed	Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors.	GRIN3A GRIN1	5.57e-05	2	260	2	11160393
Pubmed	Silencing of Ac45 Simultaneously Inhibits Osteoclast-Mediated Bone Resorption and Attenuates Dendritic Cell-Mediated Inflammation through Impairing Acidification and Cathepsin K Secretion.	ATP6AP1 CTSK	5.57e-05	2	260	2	33077625
Pubmed	Simultaneous disturbance of NHE1 and LOXL2 decreases tumorigenicity of head and neck squamous cell carcinoma.	SLC9A1 LOXL2	5.57e-05	2	260	2	38520980
Pubmed	Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex.	GRIN3A GRIN1	5.57e-05	2	260	2	18296432
Pubmed	Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels.	HCN4 HCN1	5.57e-05	2	260	2	17548059
Pubmed	Cardiac Involvement in LAMA2-Related Muscular Dystrophy and SELENON-Related Congenital Myopathy: A Case Series.	LAMA2 SELENON	5.57e-05	2	260	2	39177608
Pubmed	Formation of NR1/NR2 and NR1/NR3 heterodimers constitutes the initial step in N-methyl-D-aspartate receptor assembly.	GRIN3A GRIN1	5.57e-05	2	260	2	17959602
Pubmed	Laminins alpha2 and alpha4 in pancreatic acinar basement membranes are required for basal receptor localization.	LAMA2 LAMA4	5.57e-05	2	260	2	14729866
Pubmed	α2δ-1 Is Essential for Sympathetic Output and NMDA Receptor Activity Potentiated by Angiotensin II in the Hypothalamus.	CACNA2D1 GRIN1	5.57e-05	2	260	2	29921713
Pubmed	Excitatory GluN1/GluN3A glycine receptors (eGlyRs) in brain signaling.	GRIN3A GRIN1	5.57e-05	2	260	2	37248111
Pubmed	Mice lacking a functional chk gene have no apparent defects in the hematopoietic system.	MATK CASP1	5.57e-05	2	260	2	9315289
Pubmed	Activation-induced structural change in the GluN1/GluN3A excitatory glycine receptor.	GRIN3A GRIN1	5.57e-05	2	260	2	25017909
Pubmed	Colocalization of hyperpolarization-activated, cyclic nucleotide-gated channel subunits in rat retinal ganglion cells.	HCN4 HCN1	5.57e-05	2	260	2	21456027
Pubmed	Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli.	HCN4 HCN1	5.57e-05	2	260	2	11675786
Pubmed	Inactivation of AMMECR1 is associated with growth, bone, and heart alterations.	AMMECR1L AMMECR1	5.57e-05	2	260	2	29193635
Pubmed	Loss of NR1 subunit of NMDARs in primary sensory neurons leads to hyperexcitability and pain hypersensitivity: involvement of Ca(2+)-activated small conductance potassium channels.	GRIN1 AVIL	5.57e-05	2	260	2	23946399
Pubmed	Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death.	HK2 TIGAR	5.57e-05	2	260	2	23185017
Pubmed	The human olfactory receptor gene family.	OR7A5 OR6K2 OR2W1 OR2M5 OR2M3 OR52B4 OR2Z1 OR4D5 OR56B4 OR8I2 OR6K6 OR4K14 OR51V1 OR2A2	6.53e-05	541	260	14	14983052
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	7.18e-05	30	260	4	38786026
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	MYO7B ARHGEF17 RCC2 HNRNPL DNHD1 EXOSC10 RBM39 DHX30 TNPO3	7.32e-05	234	260	9	36243803
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	HSPG2 LAMA2 LAMA4	8.64e-05	12	260	3	16750824
Pubmed	LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance.	PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	9.31e-05	32	260	4	37889087
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	HK2 MYOM1 TRIO SPTBN1 HSPG2 EXOSC10 ANKFY1 COL12A1 LAMA2 LAMA4 XIRP2 CDK5RAP2 SNAPC3	1.07e-04	497	260	13	23414517
Pubmed	The DNA sequence and biological annotation of human chromosome 1.	LRRC39 PRAMEF25 PRAMEF9 OR2M2 OR2M3 SLC35E2B ZBTB37 CAMTA1 PRAMEF11 RHBG PRAMEF12 PRAMEF4 STIL SELENON OR6K6 SLC9A1 MMEL1 DENND2C DOCK7 PATJ	1.09e-04	1031	260	20	16710414
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 ATXN2L SPTBN1 RCC2 UTP20 PHIP USP47 EXOSC10 COPG1 UBR4 COPG2 RBM39 DHX30 FANCI DOCK7	1.35e-04	653	260	15	22586326
Pubmed	The transcription factors Grainyhead-like 2 and NK2-homeobox 1 form a regulatory loop that coordinates lung epithelial cell morphogenesis and differentiation.	PLXNB2 PLXNB1 SEMA3C	1.41e-04	14	260	3	22955271
Pubmed	Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways.	GRIN3A CASP1 GRIN1	1.41e-04	14	260	3	15749123
Interaction	C1orf54 interactions	MBTPS1 MAN2A1 PLXNB2 WNT16 PKD1 UGT3A2 SEMA3C VWA1 SELENON LRIG1 LOXL2 SCARB1	8.32e-07	167	241	12	int:C1orf54
Interaction	FBXO2 interactions	EMC3 HK2 BACE1 PLXNB2 LRP1B ERAP2 HSPG2 CACNA2D1 SEMA3C COL12A1 LAMA4 GRIN1 SELENON MEGF8 LRIG1 LOXL2 SCARB1 SORL1	2.47e-06	411	241	18	int:FBXO2
Cytoband	1p36.21	PRAMEF25 PRAMEF9 PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4	7.28e-08	63	260	7	1p36.21
Cytoband	Ensembl 112 genes in cytogenetic band chr1p36	PRAMEF25 PRAMEF9 SLC35E2B RCC2 CAMTA1 PRAMEF26 PRAMEF11 HSPG2 EXOSC10 UBR4 PRAMEF15 PRAMEF12 VWA1 PRAMEF4 SELENON SLC9A1 MMEL1 PRAMEF27	8.76e-08	681	260	18	chr1p36
GeneFamily	PRAME family	PRAMEF25 PRAMEF9 PRAMEF26 PRAMEF11 PRAMEF15 PRAMEF12 PRAMEF4 PRAMEF27	6.89e-11	24	186	8	686
GeneFamily	Solute carriers	SLC17A2 SLC35E2B SLC30A4 SLC25A32 SLC26A8 SLC9A7 RHBG SLC43A1 SLC35G4 SLC4A1 SLC5A11 SLC9A1 SLC30A5	2.34e-04	395	186	13	752
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC17A2 MYO7B LRP1B FREM1 RYR3 HEPHL1 TRHDE VWA3A COL12A1 DNAH10 HCN1 LAMA2	1.94e-10	160	260	12	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC17A2 MYO7B LRP1B FREM1 RYR3 HEPHL1 TRHDE VWA3A COL12A1 DNAH10 HCN1 LAMA2	1.94e-10	160	260	12	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 MYO7B LRP1B FREM1 RYR3 NRXN1 TRHDE COL12A1 DNAH10 DNAH1 XIRP2	1.22e-08	184	260	11	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 MYO7B LRP1B FREM1 RYR3 NRXN1 TRHDE COL12A1 DNAH10 DNAH1 XIRP2	1.22e-08	184	260	11	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HECW1 MYO7B LRP1B FREM1 RYR3 NRXN1 TRHDE COL12A1 DNAH10 DNAH1 XIRP2	1.22e-08	184	260	11	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	ABCA9 ABCA8 FREM1 GLP2R CACNA2D1 LAMA2 LAMA4 GREB1 PRKG1 ANKFN1 TNXB	1.29e-08	185	260	11	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA9 ABCA8 GLP2R SEMA3C COL12A1 LAMA2 LAMA4 PLXDC2 GREB1 CTSK TNXB	2.22e-08	195	260	11	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HECW1 ABCA9 ABCA8 FREM1 AHRR TRHDE LAMA2 LAMA4 PLXDC2 PRKG1 TNXB	2.88e-08	200	260	11	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	facs-Lung-Endomucin-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 MATK IREB2 PHKA1 PZP UVRAG SHLD2 RHBG ZBTB49 GUCY2C	5.27e-08	166	260	10	a2ce44702a0cd5fa5872cac3302d3c451205feef
ToppCell	facs-Lung-Endomucin-3m-Myeloid-myeloid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HK2 MATK IREB2 PHKA1 PZP UVRAG SHLD2 RHBG ZBTB49 GUCY2C	5.27e-08	166	260	10	0f641302a6b71c4badaaf20f51162bfc2386b167
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 ST8SIA5 TMEM117 SEMA3C RHBG LAMA2 SYT10 SLC4A1 ATP6V0A4 PRKG1	8.66e-08	175	260	10	77c16e615c0fb9c83f29d7e0a547be72635fac81
ToppCell	COVID-19-kidney-CD-IC-A\|kidney / Disease (COVID-19 only), tissue and cell type	FREM1 ST8SIA5 TMEM117 SEMA3C RHBG LAMA2 SYT10 SLC4A1 ATP6V0A4 PRKG1	1.32e-07	183	260	10	5c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FREM1 ST8SIA5 TMEM117 SEMA3C RHBG SYT10 SLC4A1 BCO2 ATP6V0A4	1.53e-07	186	260	10	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MYO10 ABCA8 FREM1 SLITRK6 CACNA2D1 LAMA2 LAMA4 GUCY1A2 PLXDC2 PRKG1	1.61e-07	187	260	10	a9316e2818217ec5feae9cf8816f7249803caee6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FREM1 ASAP2 PRKAG2 TMEM117 TPST1 RHBG SLC4A1 ATP6V0A4 PRKG1	1.78e-07	189	260	10	a9864873b19ab3e60acf11f288fa7275badc2e42
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	ABCA9 ABCA8 GLP2R CACNA2D1 LAMA2 LAMA4 GUCY1A2 GREB1 ANKFN1 TNXB	1.87e-07	190	260	10	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ABCA9 ABCA8 FREM1 CACNA2D1 LAMA2 LAMA4 GUCY1A2 PLXDC2 PRKG1 TNXB	1.87e-07	190	260	10	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FREM1 PRKAG2 TMEM117 TPST1 SEMA3C RHBG SLC4A1 ATP6V0A4 PRKG1	1.87e-07	190	260	10	b3bccf4dd95e986db3cee324a6737f5fcc22e8e5
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN LAMA2 LAMA4 GUCY1A2 PRKG1 ANKFN1 TNXB	1.96e-07	191	260	10	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN LAMA2 LAMA4 GUCY1A2 PRKG1 ANKFN1 TNXB	1.96e-07	191	260	10	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAN1A1 ABCA9 SEMA3C LAMA2 LAMA4 SELENON PLXDC2 LOXL2 CTSK TNXB	2.06e-07	192	260	10	beac6b3c191b11add8e39e8d04562b478ea8929e
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYN3 MYO10 ABCA9 FREM1 TRHDE CACNA2D1 LAMA2 LAMA4 PRKG1 TNXB	2.16e-07	193	260	10	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.26e-07	194	260	10	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.37e-07	195	260	10	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN SEMA3C COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.49e-07	196	260	10	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYO10 ABCA8 FREM1 PZP TRHDE SLC43A1 LAMA4 PLXDC2 SYTL4 TNXB	2.61e-07	197	260	10	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.61e-07	197	260	10	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.61e-07	197	260	10	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	facs-Trachea-nan-3m-Mesenchymal-fibroblast\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 TPST1 SEMA3C LAMA2 LAMA4 SELENON PLXDC2 LOXL2 CTSK TNXB	2.73e-07	198	260	10	0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO10 ABCA8 FREM1 SLITRK6 PZP LAMA4 PLXDC2 SYTL4 PRKG1 TNXB	2.86e-07	199	260	10	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SPTBN1 ABCA8 FREM1 PZP TRHDE LAMA4 PLXDC2 SYTL4 PRKG1 TNXB	3.00e-07	200	260	10	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA9 ABCA8 FREM1 TRHDE COL12A1 LAMA2 LAMA4 PLXDC2 PRKG1 TNXB	3.00e-07	200	260	10	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYN3 MYO10 ABCA9 ABCA8 FREM1 TRHDE LAMA2 LAMA4 PLXDC2 TNXB	3.00e-07	200	260	10	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 PRKAG2 TMEM117 SEMA3C RHBG USP29 SLC4A1 MMEL1 ATP6V0A4	4.65e-07	161	260	9	176a4a72bb4892932da3c834d1fea5e211847f92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	7.34e-07	170	260	9	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	7.34e-07	170	260	9	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ANKRD29 FREM1 ST8SIA5 TMEM117 SEMA3C RHBG SYT10 SLC4A1 ATP6V0A4	9.35e-07	175	260	9	1d8da48236549c01381f777ce5b2937f9f86acc2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 ST8SIA5 TMEM117 SEMA3C RHBG SYT10 SLC4A1 ATP6V0A4 PRKG1	9.35e-07	175	260	9	98947a226b5a2ac7091ff9d34243ea7736add973
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FREM1 ST8SIA5 TMEM117 SEMA3C RHBG SYT10 SLC4A1 BCO2 ATP6V0A4	9.81e-07	176	260	9	25ebc8716aa44e44fce577701e3e82c6745a75ab
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATP2C2 ST8SIA5 TMEM117 SEMA3C RHBG SYT10 SLC4A1 ATP6V0A4 PRKG1	9.81e-07	176	260	9	c2c4306476989bc2fb30dab00250ef7915842f13
ToppCell	356C-Fibroblasts-Fibroblast-E-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PDE6A ABCA9 ABCA8 SEMA3C LAMA4 LIPC GREB1 CTSK TNXB	1.08e-06	178	260	9	a493a277d175e5e153410a745b26ebe2e0839ea0
ToppCell	356C-Fibroblasts-Fibroblast-E\|356C / Donor, Lineage, Cell class and subclass (all cells)	PDE6A ABCA9 ABCA8 SEMA3C LAMA4 LIPC GREB1 CTSK TNXB	1.08e-06	178	260	9	371218babddfd3d8a7bb82a46ce65327ee3fcf12
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FREM1 TMEM117 SEMA3C RHBG SYT10 SLC4A1 ATP6V0A4 PRKG1	1.13e-06	179	260	9	e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ATP6AP1 HCAR1 ATP2C2 TMEM117 SEMA3C RHBG SYT10 SLC4A1 ATP6V0A4	1.13e-06	179	260	9	27ad6a609fe1f7532b142d0147bccf918704a6dd
ToppCell	AT1_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD29 SPTBN1 BCAT2 ABCA8 NBEAL2 HSPG2 COL12A1 LIPC MSLN	1.18e-06	180	260	9	2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2
ToppCell	AT1_cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD29 HELT SPTBN1 BCAT2 ABCA8 ABCD1 COL12A1 LIPC MSLN	1.18e-06	180	260	9	ff4728782c3ec814ba071cc22b7894abdd9da837
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FREM1 TMEM117 SEMA3C RHBG SYT10 SLC4A1 BCO2 ATP6V0A4	1.24e-06	181	260	9	30729f0364f719c044712a51453e22dc2c1a232b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 ANKFN1	1.30e-06	182	260	9	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	COVID-19-kidney-CD-IC-B\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FREM1 ASAP2 FHIP1A TMEM117 TRHDE SEMA3C RHBG BCO2 ATP6V0A4	1.30e-06	182	260	9	ee6a8c356bbbdae55e4ea858337e079491f9f4aa
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 ANKFN1	1.30e-06	182	260	9	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ACSM1 ABCA9 ABCA8 HSPG2 COL12A1 LAMA2 GUCY1A2 PRKG1 TNXB	1.30e-06	182	260	9	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	1.42e-06	184	260	9	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ABCA9 ABCA8 FREM1 NALCN CACNA2D1 LAMA2 PLXDC2 GREB1 SETD7	1.42e-06	184	260	9	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FREM1 ASAP2 PRKAG2 TMEM117 RHBG SLC4A1 ATP6V0A4 PRKG1	1.48e-06	185	260	9	3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d
ToppCell	facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP2C2 CFAP70 VWA3A DNAH10 SYT10 TSPAN1 DNAH1 WDR19 ANKFN1	1.62e-06	187	260	9	04dba2ed09ee4180830bdf0191921696697ea234
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	HECW1 ABCA9 NALCN CACNA2D1 LAMA2 LAMA4 PLXDC2 PRKG1 TNXB	1.62e-06	187	260	9	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	SYN3 ABCA9 ABCA8 TRHDE LAMA2 LAMA4 PLXDC2 PRKG1 TNXB	1.62e-06	187	260	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP2C2 CFAP70 VWA3A DNAH10 SYT10 TSPAN1 DNAH1 WDR19 ANKFN1	1.62e-06	187	260	9	805dafe22f835ece4dd091d8030d0a63b52a48dd
ToppCell	COVID-19-kidney-CD-IC-B\|kidney / Disease (COVID-19 only), tissue and cell type	MYO10 FREM1 ASAP2 TMEM117 SEMA3C RHBG LAMA2 BCO2 ATP6V0A4	1.62e-06	187	260	9	ce05b89860573fe0356102e2998d1ef6d1968034
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	ABCA9 ABCA8 FREM1 GLP2R CACNA2D1 LAMA2 PLXDC2 GREB1 TNXB	1.69e-06	188	260	9	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO10 FREM1 ST8SIA5 TMEM117 SEMA3C RHBG SLC4A1 BCO2 ATP6V0A4	1.69e-06	188	260	9	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	1.77e-06	189	260	9	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 ABCA8 FREM1 TRHDE VWA3A CACNA2D1 LAMA2 LAMA4 PLXDC2	1.77e-06	189	260	9	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	1.77e-06	189	260	9	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYO10 ABCA8 FREM1 PZP TRHDE LAMA4 GUCY1A2 PLXDC2 PRKG1	1.77e-06	189	260	9	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN SEMA3C COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1	1.93e-06	191	260	9	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN SEMA3C COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1	1.93e-06	191	260	9	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.02e-06	192	260	9	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.02e-06	192	260	9	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.02e-06	192	260	9	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.02e-06	192	260	9	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	ABCA9 ABCA8 GLP2R LAMA2 LAMA4 GUCY1A2 GREB1 ANKFN1 TNXB	2.02e-06	192	260	9	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 CHST15 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1	2.10e-06	193	260	9	f1199518c3626fd29bfce65070dd21a660671213
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SYN3 MYO10 ABCA9 TRHDE CACNA2D1 LAMA2 LAMA4 PRKG1 TNXB	2.20e-06	194	260	9	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYO10 ABCA8 FREM1 TRHDE CACNA2D1 LAMA2 LAMA4 PLXDC2 PRKG1	2.20e-06	194	260	9	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 PLXNB2 FREM1 PRKAG2 TMEM117 RHBG TSPAN1 ASS1 ANKFN1	2.20e-06	194	260	9	4579b4a44f7c731553a284843c296866027d7c0e
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SPTBN1 RCC2 ASAP2 ATP2C2 STIL SYT10 BCO2 FANCI MSLN	2.20e-06	194	260	9	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	10x5'v1-week_12-13-Hematopoietic-MK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MYOM1 FREM1 PGAP4 CAPN11 SLC30A5 PLXDC2 SYTL4 DENND2C PRKG1	2.20e-06	194	260	9	245a3eb6db9c862b73ad34a8cd2898a3688c16f6
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN1 PLXNB2 FREM1 PRKAG2 TMEM117 RHBG TSPAN1 ASS1 ANKFN1	2.29e-06	195	260	9	3d6d3de8ada6dce3dc789c15b50cc066e7100496
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ACSM1 ABCA9 ABCA8 ASAP2 TPST1 COL12A1 LAMA2 PLXDC2 TNXB	2.29e-06	195	260	9	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.29e-06	195	260	9	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LRP1B ABCA9 ABCA8 HSPG2 COL12A1 LAMA2 LAMA4 ASS1 PRKG1	2.49e-06	197	260	9	3bb92dd8a94e2be3b7fe51c9a21b241215477ac7
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OR2M3 ABCA9 FREM1 TRHDE LAMA2 LAMA4 PLXDC2 ZFP92 TNXB	2.49e-06	197	260	9	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LRP1B ABCA9 ABCA8 HSPG2 COL12A1 LAMA2 LAMA4 ASS1 PRKG1	2.49e-06	197	260	9	17344464fdcc5ba0c03959696b97c195f11e644c
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA9 ABCA8 GLP2R SEMA3C COL12A1 LAMA2 PLXDC2 CTSK TNXB	2.49e-06	197	260	9	c747c496ac090309b7f8a3e9d840928f12c83f2f
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_endoneurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ACSM1 ABCA9 ABCA8 NALCN IFI44L HCN1 LAMA2 GEMIN7 BCO2	2.49e-06	197	260	9	6806ec223e542f0475303698eb78c1cc527f5c6b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA9 ABCA8 NALCN SEMA3C COL12A1 LAMA2 LAMA4 GUCY1A2 PRKG1	2.49e-06	197	260	9	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LRP1B ABCA9 ABCA8 HSPG2 COL12A1 LAMA2 LAMA4 ASS1 PRKG1	2.49e-06	197	260	9	5b8d0d7116b20d8e27541e88ec80c9f1f477e384
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	ABCA9 ABCA8 FREM1 LAMA2 LAMA4 GUCY1A2 GREB1 PRKG1 TNXB	2.60e-06	198	260	9	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA8 FREM1 TPST1 CACNA2D1 LAMA2 LAMA4 GUCY1A2 PLXDC2 PRKG1	2.60e-06	198	260	9	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	ABCA9 ABCA8 CHST15 COL12A1 LAMA2 LAMA4 GUCY1A2 LOXL2 PRKG1	2.60e-06	198	260	9	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYO10 ABCA8 FREM1 PZP LAMA4 PLXDC2 SYTL4 PRKG1 TNXB	2.71e-06	199	260	9	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	ABCA9 ABCA8 CHST15 COL12A1 LAMA2 LAMA4 GUCY1A2 LOXL2 PRKG1	2.71e-06	199	260	9	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	ABCA9 ABCA8 FREM1 CACNA2D1 LAMA2 LAMA4 GUCY1A2 PRKG1 TNXB	2.71e-06	199	260	9	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	ABCA8 FREM1 SLITRK6 PZP TRHDE LAMA4 PLXDC2 SYTL4 TNXB	2.82e-06	200	260	9	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA9 ABCA8 FREM1 TRHDE LAMA2 LAMA4 PLXDC2 PRKG1 TNXB	2.82e-06	200	260	9	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYO10 ABCA8 FREM1 PZP LAMA4 PLXDC2 SYTL4 PRKG1 TNXB	2.82e-06	200	260	9	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA9 ABCA8 TPST1 COL12A1 LAMA2 LAMA4 PLXDC2 CTSK TNXB	2.82e-06	200	260	9	933b5b400e48a511ba0a056be1d33d3610b5f10d
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA9 ABCA8 TPST1 SEMA3C COL12A1 LAMA2 PLXDC2 CTSK TNXB	2.82e-06	200	260	9	cfea2f9d85646c9b722150551ff2e8fc4f6cc98a
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	ABCA8 FREM1 SLITRK6 PZP TRHDE LAMA4 PLXDC2 SYTL4 TNXB	2.82e-06	200	260	9	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
Disease	diabetic foot	SLC26A8 MAPK14	6.75e-05	2	243	2	EFO_1001459
Disease	sick sinus syndrome (implicated_via_orthology)	HCN4 HCN1	2.02e-04	3	243	2	DOID:13884 (implicated_via_orthology)
Disease	Paroxysmal atrial fibrillation	USP34 HSPG2 DNAH10 HCN4 WNT8A LRIG1 SORL1	3.24e-04	156	243	7	C0235480
Disease	familial atrial fibrillation	USP34 HSPG2 DNAH10 HCN4 WNT8A LRIG1 SORL1	3.24e-04	156	243	7	C3468561
Disease	Persistent atrial fibrillation	USP34 HSPG2 DNAH10 HCN4 WNT8A LRIG1 SORL1	3.24e-04	156	243	7	C2585653
Disease	Atrial Fibrillation	USP34 HSPG2 DNAH10 HCN4 WNT8A LRIG1 SORL1	3.78e-04	160	243	7	C0004238
Disease	renal tubular acidosis (is_implicated_in)	SLC4A1 ATP6V0A4	4.01e-04	4	243	2	DOID:14219 (is_implicated_in)
Disease	Primary biliary cirrhosis	MAPK14 MMEL1 LOXL2 TNPO3	6.06e-04	47	243	4	C0008312
Disease	Distal Renal Tubular Acidosis	SLC4A1 ATP6V0A4	6.64e-04	5	243	2	C1704380
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	HCAR1 BCAT2 ABCA8 DNAH10 DNAH1 LIPC SCARB1 DOCK7	9.65e-04	243	243	8	EFO_0004612, EFO_0020944
Disease	level of Phosphatidylcholine (18:2_18:2) in blood serum	LIPC DOCK7	9.91e-04	6	243	2	OBA_2045106
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	BCAT2 ABCA8 STARD3 UVRAG CERS2 DNAH10 LIPC SCARB1 DOCK7	1.28e-03	315	243	9	EFO_0004612, EFO_0008591
Disease	free cholesterol in medium HDL measurement	ABCA8 CERS2 LIPC SCARB1	1.34e-03	58	243	4	EFO_0022267
Disease	cholesteryl ester measurement	BCAT2 ABCA8 CERS2 DNAH10 SDR42E1 LIPC SCARB1 DOCK7	1.38e-03	257	243	8	EFO_0010351
Disease	birth measurement, spontaneous preterm birth	MAN1A1 SORL1	1.38e-03	7	243	2	EFO_0006917, EFO_0006921
Disease	cholesterol in medium HDL measurement	ABCA8 CERS2 LIPC SCARB1	1.43e-03	59	243	4	EFO_0021903
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	HCAR1 BCAT2 ABCA8 STARD3 CERS2 DNAH10 LIPC SCARB1 DOCK7	1.46e-03	321	243	9	EFO_0004612, EFO_0004639
Disease	Adenocarcinoma of lung (disorder)	CYP2A13 HK2 ATR EIF2B5 EML4 CREBBP MAPK14	1.66e-03	206	243	7	C0152013
Disease	free cholesterol in very large HDL measurement	BCAT2 LIPC SCARB1 DOCK7	1.72e-03	62	243	4	EFO_0022273
Disease	lipid measurement, high density lipoprotein cholesterol measurement	HCAR1 BCAT2 ABCA8 STARD3 CERS2 DNAH10 LIPC SCARB1 DOCK7	1.76e-03	330	243	9	EFO_0004529, EFO_0004612
Disease	lipoprotein measurement	ABCA8 CERS2 LIPC SCARB1 DOCK7	1.80e-03	105	243	5	EFO_0004732
Disease	Muscular Dystrophy	LAMA2 SELENON	1.83e-03	8	243	2	C0026850
Disease	severe pre-eclampsia (is_marker_for)	ACVR1 ERAP2	1.83e-03	8	243	2	DOID:13129 (is_marker_for)
Disease	cathepsin S measurement	CERS2 CTSK	1.83e-03	8	243	2	EFO_0008073
Disease	female breast cancer (is_implicated_in)	PALB2 FANCI	1.83e-03	8	243	2	DOID:0050671 (is_implicated_in)
Disease	renal tubular acidosis (implicated_via_orthology)	SLC4A1 ATP6V0A4	1.83e-03	8	243	2	DOID:14219 (implicated_via_orthology)
Disease	level of Phosphatidylcholine (18:1_18:1) in blood serum	LIPC DOCK7	1.83e-03	8	243	2	OBA_2045099
Disease	cholesterol to total lipids in very large HDL percentage	LIPC SCARB1 DOCK7	2.09e-03	31	243	3	EFO_0022243
Disease	obesity (implicated_via_orthology)	PLXNB2 GNRHR PLXNB1 DNAH10 CAPN11 LIPC GUCY2C	2.12e-03	215	243	7	DOID:9970 (implicated_via_orthology)
Disease	coronary artery disease	NR2C1 SYN3 PCNX3 RGS19 ABCA8 ASAP2 NRXN1 PLEKHA7 OR56B4 SEMA3C DNAH10 HCN4 HCN1 AP4E1 GLMN LIPC GUCY1A2 SCARB1 PRKG1 TNXB	2.21e-03	1194	243	20	EFO_0001645
Disease	glycogen storage disease (is_implicated_in)	PHKA1 PRKAG2	2.34e-03	9	243	2	DOID:2747 (is_implicated_in)
Disease	phospholipids:total lipids ratio	SLC17A2 BCAT2 ABCA8 CERS2 LIPC SCARB1 DOCK7	2.87e-03	227	243	7	EFO_0020946
Disease	high density lipoprotein particle size measurement	HCAR1 STARD3 UVRAG DNAH10 LIPC SCARB1	2.93e-03	170	243	6	EFO_0008592
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HCAR1 BCAT2 ABCA8 CERS2 DNAH10 LIPC SCARB1 DOCK7	2.98e-03	291	243	8	EFO_0008317, EFO_0020946
Disease	colon cancer (is_implicated_in)	ATR LRP1B MAPK14	3.22e-03	36	243	3	DOID:219 (is_implicated_in)
Disease	cholesterol in small HDL measurement	CERS2 LIPC DOCK7	3.22e-03	36	243	3	EFO_0022226
Disease	cholesteryl esters to total lipids in medium LDL percentage	BCAT2 LIPC DOCK7	3.49e-03	37	243	3	EFO_0022252
Disease	Other specified cardiac arrhythmias	CACNA2D1 HCN4	3.54e-03	11	243	2	C0348626
Disease	Nodal rhythm disorder	CACNA2D1 HCN4	3.54e-03	11	243	2	C0264893
Disease	maleate measurement	LIPC PRKG1	3.54e-03	11	243	2	EFO_0010509
Disease	Ectopic rhythm	CACNA2D1 HCN4	3.54e-03	11	243	2	C1399226
Disease	cell growth regulator with EF hand domain protein 1 measurement	CPNE1 PLXDC2	3.54e-03	11	243	2	EFO_0801461
Disease	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	CACNA2D1 HCN4	3.54e-03	11	243	2	C2748542
Disease	atrial fibrillation	USP34 HCFC2 HSPG2 DNAH10 HCN4 WNT8A LRIG1 PCCA SORL1	3.83e-03	371	243	9	EFO_0000275
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	LIPC DOCK7	4.22e-03	12	243	2	OBA_2045157
Disease	Congenital muscular dystrophy	LAMA2 SELENON	4.22e-03	12	243	2	cv:C0699743
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	HCAR1 ABCA8 STARD3 CERS2 DNAH10 LIPC SCARB1 DOCK7	4.53e-03	312	243	8	EFO_0004612, EFO_0010351
Disease	Alzheimer disease, educational attainment	ATXN2L BCAT2 LRP1B NRXN1 HCN1 RBM23 SORL1	4.55e-03	247	243	7	EFO_0011015, MONDO_0004975
Disease	apolipoprotein A 1 measurement	STIMATE HCAR1 BACE1 BCAT2 ABCA9 ABCA8 STARD3 UVRAG PHIP CERS2 DNAH10 LIPC SCARB1 DOCK7 SORL1	4.74e-03	848	243	15	EFO_0004614
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	HCAR1 ABCA8 STARD3 CERS2 DNAH10 LIPC SCARB1 DOCK7	4.79e-03	315	243	8	EFO_0004574, EFO_0004612
Disease	sexual dimorphism measurement	ATXN2L SYN3 BACE1 ABCA8 PKD1 CPNE1 PHIP DNAH10 RBM39 SLC4A1 LIPC MAPK14 LOXL2 SCARB1 AVIL ASS1 PATJ RAPGEFL1	4.89e-03	1106	243	18	EFO_0021796
Disease	velocity of sound measurement	SPTBN1 WNT16	4.96e-03	13	243	2	EFO_0005654
Disease	RAC-beta serine/threonine-protein kinase measurement	SYN3 GPLD1	4.96e-03	13	243	2	EFO_0021989
Disease	iron deficiency anemia (biomarker_via_orthology)	IREB2 SLC4A1	4.96e-03	13	243	2	DOID:11758 (biomarker_via_orthology)
Disease	Brugada Syndrome 1	CACNA2D1 HCN4	4.96e-03	13	243	2	C4551804
Disease	Connective Tissue Diseases	ACVR1 PKD1	4.96e-03	13	243	2	C0009782
Disease	hypothyroidism (implicated_via_orthology)	PHKA1 LIPC	4.96e-03	13	243	2	DOID:1459 (implicated_via_orthology)
Disease	Secondary Biliary Cholangitis	MAPK14 MMEL1 LOXL2	5.00e-03	42	243	3	C0238065
Disease	Biliary cirrhosis	MAPK14 MMEL1 LOXL2	5.00e-03	42	243	3	C0023892
Disease	Biliary Cirrhosis, Primary, 1	MAPK14 MMEL1 LOXL2	5.00e-03	42	243	3	C4551595
Disease	cholesteryl esters to total lipids in small HDL percentage	BCAT2 LIPC DOCK7	5.34e-03	43	243	3	EFO_0022254
Disease	cholesterol in medium VLDL measurement	BCAT2 LIPC DOCK7	5.70e-03	44	243	3	EFO_0022225
Disease	Fanconi anemia	PALB2 FANCI	5.76e-03	14	243	2	cv:C0015625
Disease	glucose-dependent insulinotropic peptide measurement, glucose tolerance test	ARHGEF17 GLP2R	5.76e-03	14	243	2	EFO_0004307, EFO_0008464
Disease	Impaired cognition	EIF2B5 SORL1	5.76e-03	14	243	2	C0338656
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	LIPC DOCK7	5.76e-03	14	243	2	OBA_2045100
Disease	lysophosphatidylcholine 15:0 measurement	LRP1B LIPC	5.76e-03	14	243	2	EFO_0020941
Disease	forced expiratory volume	SLC17A2 ATXN2L IREB2 ARHGEF17 PLXNB2 IFI44L PHIP EML4 STIL SCARB1 PRKG1 CTNND2 ANKFN1 TNXB	6.10e-03	789	243	14	EFO_0004314
Disease	platelet storage pool deficiency (implicated_via_orthology)	HPS1 DOCK7	6.61e-03	15	243	2	DOID:2223 (implicated_via_orthology)
Disease	Hepatitis C	LOXL2 SCARB1	6.61e-03	15	243	2	C0019196
Disease	Lymphoma, Follicular, Grade 2	ATP6AP1 CREBBP	6.61e-03	15	243	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	ATP6AP1 CREBBP	6.61e-03	15	243	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	ATP6AP1 CREBBP	6.61e-03	15	243	2	C1956130
Disease	granulysin measurement	ERAP2 CPNE1	6.61e-03	15	243	2	EFO_0008144
Disease	Autosomal recessive primary microcephaly	STIL CDK5RAP2	6.61e-03	15	243	2	cv:C3711387
Disease	Lymphoma, Large-Cell, Follicular	ATP6AP1 CREBBP	6.61e-03	15	243	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	ATP6AP1 CREBBP	6.61e-03	15	243	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	ATP6AP1 CREBBP	6.61e-03	15	243	2	C0079758
Disease	nasopharynx carcinoma (is_implicated_in)	MST1R MAPK14	6.61e-03	15	243	2	DOID:9261 (is_implicated_in)
Disease	level of Phosphatidylcholine (O-18:1_20:4) in blood serum	LIPC SCARB1	6.61e-03	15	243	2	OBA_2045131
Disease	anemia (implicated_via_orthology)	IREB2 SLC4A1	6.61e-03	15	243	2	DOID:2355 (implicated_via_orthology)
Disease	Sinus Node Dysfunction (disorder)	CACNA2D1 HCN4	6.61e-03	15	243	2	C0428908
Disease	frontal fibrosing alopecia	NR2C1 MYO10 ERAP2	7.26e-03	48	243	3	EFO_0009855
Disease	phosphoglycerides measurement	LIPC SCARB1 DOCK7	7.26e-03	48	243	3	EFO_0022291
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	ABCA8 DNAH10 DNAH1 LIPC SCARB1 DOCK7	7.39e-03	206	243	6	EFO_0004612, EFO_0020947
Disease	Neuralgia, Supraorbital	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0038870
Disease	Neuralgia	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0027796
Disease	idiopathic scoliosis (implicated_via_orthology)	MBTPS1 DNAH10	7.51e-03	16	243	2	DOID:0060250 (implicated_via_orthology)
Disease	pancreatic ductal carcinoma (is_implicated_in)	PMS1 MSLN	7.51e-03	16	243	2	DOID:3587 (is_implicated_in)
Disease	Neuralgia, Atypical	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0234247
Disease	Neuralgia, Stump	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0423712
Disease	Neuralgia, Perineal	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0423711
Disease	Paroxysmal Nerve Pain	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0751373
Disease	Nerve Pain	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0751372
Disease	Neuralgia, Ilioinguinal	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0751371
Disease	Neuralgia, Vidian	CACNA2D1 PRKG1	7.51e-03	16	243	2	C0042656
Disease	level of Phosphatidylcholine (18:0_18:2) in blood serum	LIPC DOCK7	7.51e-03	16	243	2	OBA_2045090
Disease	body fat percentage	ATXN2L MAN1A1 NRXN1 SLITRK6 CAMTA1 DNAH10 SLC4A1 MST1R LRIG1 PATJ	7.57e-03	488	243	10	EFO_0007800
Disease	Pain, Migratory	CACNA2D1 GRIN1 SLC9A1	7.69e-03	49	243	3	C0751407

Protein segments in the cluster

Peptide	Gene	Start	Entry
ISSVTVFYLGQHAME	TPST1	16	O60507
MGHSVFQRGLQDYLT	TRHDE	541	Q9UKU6
ATIVDYLGFHQTDVM	AHRR	141	A9YTQ3
DHLSYNTLMAIFREV	BHLHB9	526	Q6PI77
NLEASLGVHTYELAM	CTSK	61	P43235
GMLTITDFINILHRY	PRKAG2	316	Q9UGJ0
LYLMGEVTNQSFRIT	BACE1	346	P56817
LREMEHYFSQGLSVQ	PGM3	221	O95394
MLYHISDSAGQLAVT	AVIL	251	O75366
MTLLHLAAAQGYATL	CAMTA1	1066	Q9Y6Y1
TFSAMNLHSGLREYT	AMMECR1L	156	Q6DCA0
VMIFELAYHVQSFLS	EIF2AK4	121	Q9P2K8
IDAYMAQSRGELLHS	SLC4A1	296	P02730
TVGMAQLIHLDYDVN	ABCA9	371	Q8IUA7
YQTVMLRHENILGFI	ACVR1B	251	P36896
LYNTVMLRHENILGF	ACVR1	251	Q04771
LLAASQYGHMQVVET	ANKRD29	116	Q8N6D5
MLVELHTQGQDRFVY	CREBBP	1691	Q92793
QTYERFSHVAMILGK	CNOT9	201	Q92600
LQAVRMFADYLAHES	COPE	81	O14579
NTTFLLMAASIYLHD	COPE	116	O14579
RQAMDGTVYAHSTLE	DNHD1	2476	Q96M86
DAYMHITSVLKIFQG	ADCY10	316	Q96PN6
MLVRGHAYSVTGLQD	CAPN11	291	Q9UMQ6
HSGTLNSYEMRLVIE	CAPN11	656	Q9UMQ6
THAMYNLASLRELGE	DHX30	326	Q7L2E3
HSFGMTRNYIIFIEQ	BCO2	286	Q9BYV7
LDGIMDQYLSRHFLS	BBS10	141	Q8TAM1
ANYIRAGTLIMALHD	CERS2	226	Q96G23
LSYRLAAETSQGQHM	CTNND2	771	Q9UQB3
EIGFLRNHMFLYSVL	ATP2C2	866	O75185
GTTHQTSLELFMYLN	ASS1	241	P00966
GVYNNSRMLHFLTAV	ATXN2L	116	Q8WWM7
DRDVGVMAASLHIYL	AP4E1	216	Q9UPM8
GEEMTFSSLHQVRYV	CDK5RAP2	1166	Q96SN8
KGFVDILTYIHTMNV	CPXCR1	251	Q8N123
SEQVAMGYSHSLVIA	RCC2	486	Q9P258
YVGSLHFNITEDMLR	RBM23	266	Q86U06
TITAHYTLNRQAMGE	PZP	471	P20742
QAMGELSELSFHYLI	PZP	481	P20742
LSELSFHYLIMAKGV	PZP	486	P20742
RLYVGSLHFNITEDM	RBM39	251	Q14498
HYIGESASRLLFLSM	NR2C1	391	P13056
FMSYDGIVAVILRIH	OR6K2	216	Q8NGY2
LRLHQMSVADSGEYV	HSPG2	2681	P98160
LEQRTYGLMDSHAVL	HSPG2	3156	P98160
YGLMDSHAVLQISSA	HSPG2	3161	P98160
SVESFLKVAGMQYLH	RASA4B	351	C9J798
SLYGSRHLAQLMESI	QPCTL	236	Q9NXS2
KVARYLHQSGALTME	RAB11FIP3	431	O75154
VYTIDNSTGAMLLSH	RIC1	276	Q4ADV7
VTVNATFMYSDGLIH	GUCY2C	76	P25092
MAHQINLEYLSRVVF	IREB2	251	P48200
LAQFYLAEMVLAIHS	CDC42BPG	171	Q6DT37
YGVALFNSMRHEIEG	NIBAN2	36	Q96TA1
DSFLNHMVIYFTVAL	OR7A5	191	Q15622
RLQDQHMFYSGVIDV	SLC25A32	251	Q9H2D1
LLHTDSYGRISIMQF	PPP2R3C	146	Q969Q6
ELAGYTARVHEMFQV	ABCD1	411	P33897
TLQLEHMFYVGQDSS	ARHGEF17	1846	Q96PE2
LHVSIMAGNEYVFSQ	ANKFY1	371	Q9P2R3
ASHLMAVTIFYGSLI	OR8I2	241	Q8N0Y5
ISHFLDLLSNIVMYA	FANCI	456	Q9NVI1
MYHLSGNEIISERTK	KLHL6	296	Q8WZ60
EMTVQYLRALHSADF	HELT	56	A6NFD8
SLHTASVIGNKMYIF	HCFC2	246	Q9Y5Z7
GTNMIEIIRGHEYLS	LRP1B	1456	Q9NZR2
GIESFLMYSVHEGIR	LRP1B	1876	Q9NZR2
QFSLHVAEGMEYLES	MATK	331	P42679
MEYTTILHLRQVTFG	LRIG1	556	Q96JA1
VVDYGTRLFHSLMVL	MAN2A1	581	Q16706
QHLRSMGYFVEVLGA	MBTPS1	666	Q14703
FVLVQHYAAALMAVS	GREB1	901	Q4ZG55
HSFLQESLETMDGVY	GRXCR2	51	A6NFK2
DVYLVTHLMGADLNN	MAPK14	101	Q16539
RDHLLEGTFNQVMAY	HECW1	1256	Q76N89
QIMQGAHSDFIVRLY	PRKG1	411	Q13976
YLLFLAQMTASGLHI	PHKA1	141	P46020
LGVHYSRMQSLTLDV	ASAP2	466	O43150
NEMIFKRLHLGTVSY	ATP9B	476	O43861
IVAFMLGNYINLHES	IFI44L	61	Q53G44
VIEQYSAGHLDMLSR	KCNQ3	546	O43525
RYMALIQHSTIIGFS	IL17RB	206	Q9NRM6
TGDLFYTHVTTMGQR	SLC43A1	246	O75387
FGLQFMHTYIQESRR	LRRC39	301	Q96DD0
SMEVFTHYDLLNLNG	LOXL2	631	Q9Y4K0
MIASHLLAYFFTELN	HK2	1	P52789
VTAKEYGARVSNLHM	EIF2B5	291	Q13144
MSSNLESFLYGLHAL	PCNX1	1811	Q96RV3
TVNYRLHAMFDQGEI	PCNX3	76	Q9H6A9
GTFEHLYVMTQSTLL	PLXNB1	461	O43157
AYNLTVLIEMDGHRA	PLXNB2	1066	O15031
ASYARVILAVIHMGS	OR2M2	216	Q96R28
ASYARVILAVIHMGS	OR2M3	216	Q8NG83
ASYARVILAVIHMGS	OR2M5	216	A3KFT3
MDQSNYSSLHGFILL	OR2W1	1	Q9Y3N9
TSYGHVLQAVLSMRS	OR2Z1	216	Q8NG97
YFIHGLSFMESSVLL	OR51V1	111	Q9H2C8
ISESGILLVMAFDHY	OR52B4	111	Q8NGK2
MDPQNYSLVSEFVLH	OR4K14	1	Q8NGD5
HIPQEALVRFMYSLS	PDE6A	536	P16499
VDLNLLRYTHTGAMD	FREM1	1346	Q5H8C1
FYHQMATAEGLIKRS	GANC	546	Q8TET4
LLVAMYFHSNQLSAI	INTS2	481	Q9H0H0
RERAFHTASVLGNYM	MEGF8	446	Q7Z7M0
LTELHGGSIMYNLFQ	MYO10	71	Q9HD67
YMNSVSFLEGHLDQL	PRAMEF15	276	P0DUQ1
FIDSLLHAGTQSMAY	LIPC	286	P11150
EAESGLLFYMARINH	LAMA2	2796	P24043
ESVIQHLGYLFLKMS	MSLN	366	Q13421
SMGLVELVGRHYFLE	PGAP4	301	Q9BRR3
VALATLQAYTSMHLF	NRXN1	916	Q9ULB1
MADALDNYVIRGVTH	PCCA	466	P05165
LYHRMGLEELQSQFG	MMEL1	331	Q495T6
YAMFIGHATALIQSL	HCN4	506	Q9Y3Q4
TQEHERSMAYGLVSA	MFSD14A	151	Q96MC6
NISELISQYKSHGFM	GRIN3A	886	Q8TCU5
FLSHLAIIDMSYASN	OR2A2	61	Q6IF42
HKAYSEMGLLFIVLS	PALB2	1061	Q86YC2
DMALVFSSYAVILHS	OR56B4	216	Q8NH76
LYMHSVSFLEGHLDQ	PRAMEF12	271	O95522
ITMGQLYGEFDLLTH	DNAH1	1906	Q9P2D7
LYVVNMFDTHQAARL	EXOSC10	381	Q01780
SVHLSGELYNTRTMQ	CCDC82	436	Q8N4S0
SYHLAAEEQLSFRML	CD1E	26	P15812
SRFLSQLDEHMGYLQ	ATR	176	Q13535
ASAVQNYVEHMLFLL	FHIP1A	61	Q05DH4
YAMFVGHATALIQSL	HCN1	386	O60741
NYIHMNLFASFILRT	GLP2R	211	O95838
GSVFIGRLIEHMQEY	CASP1	346	P29466
YTEAVIHEIQRFGDM	CYP2A13	351	Q16696
HASASLYLLMRQNFE	DOCK7	1571	Q96N67
VFHIASYGMSGREQL	SDR42E1	76	Q8WUS8
AFLTEMVHFILGRLY	SDR42E1	291	Q8WUS8
YIFRMIHLADSSGQT	GNRHR	176	P30968
AFVGEMTSYTLHNLN	COL12A1	2161	Q99715
SLMRHLVNISVYAFN	CACNA2D1	881	P54289
ASEMHFIFLRLGLIY	CFAP70	996	Q5T0N1
YLRSLLAMVGHQVSF	GEMIN7	66	Q9H840
TGVVFSLDMVLTRYH	GPR148	276	Q8TDV2
SSDNIMVQYHALGVL	COPG2	186	Q9UBF2
FVELVGHYSLNMTVT	DENND2C	826	Q68D51
HAGMETTYTVLRNID	HEPHL1	1056	Q6MZM0
MVNVAHDVLAAALYG	MARVELD1	96	Q9BSK0
MYFDAVQAIETHLIR	MAN1A1	436	P33908
SYDIRMIISGTTAHF	ERAP2	891	Q6P179
MADGYAVDRAITHLN	HNRNPL	426	P14866
VHGALHITLSFTYMN	HCAR1	256	Q9BXC0
SSDNIMVQYHALGLL	COPG1	186	Q9Y678
HTDGNEQLSVMRYSI	EML4	671	Q9HC35
FVGMIRHYVSILLQS	EMC3	26	Q9P0I2
MTLTFGDVVAVRHYE	FABP7	116	O15540
NVHALIEFGYSMDSI	FAM111B	676	Q6SJ93
LVHFIYVDRTTGQMV	HPS1	541	Q92902
ASSSLHYSLQLFEGM	BCAT2	91	O15382
RNIMDTLTFSIYNHG	DNAH10	3701	Q8IVF4
IMLTESLFNGSHYLD	PMS1	776	P54277
HVSTGQMEFRTLLHY	PKD1L1	1461	Q8TDX9
LQKLYMNSVSFLEGH	PRAMEF26	176	H0Y7S4
FTLHGRAILEMEQYI	NSMCE1	166	Q8WV22
LSIHSGQYRSVVDLM	R3HDML	121	Q9H3Y0
AHQGTASQYFMLLLL	CPNE1	406	Q99829
HTTMYFLLGNLSFLD	OR4D5	56	Q8NGN0
AQYSVTLHGQDVLML	PKD1	696	P98161
TLFLAHGRLVYMFNV	LAMA4	1521	Q16363
LLQMYFFHSLGITES	OR6K6	126	Q8NGW6
LLGLTEDAVYTTMHF	MOXD2P	116	A6NHM9
QVISMLNELYTRFDH	GUCY1A2	541	P33402
AFTISLLGMLVYRSH	MT-ND4L	11	P03901
HTLVANYMSGFLSLL	GPRASP1	1271	Q5JY77
MASLAYLVFVQGIHI	GLMN	286	Q92990
LYTGLVHQRGTLDVM	PIGB	401	Q92521
HTYAELMQTLRFLGL	MRPS33	56	Q9Y291
TFVYNGVRLEDLQHM	SYTL4	581	Q96C24
FILVRQHAYSMALGE	SYN3	161	O14994
EFMLAQLNYEHETGR	UTP20	2286	O75691
YTAHLVSMISFFLQV	UVRAG	366	Q9P2Y5
TFDDAQLQIYTLMHR	RGS19	176	P49795
YMFATKVVHLLGSEQ	SORL1	306	Q92673
ASVLVVSHGAYMRSL	TIGAR	191	Q9NQ88
ESFLKTQHYLLQMDG	SESN1	96	Q9Y6P5
ILRYAHMVNGFTALA	ADSS1	346	Q8N142
DVVTFIRNHPLMYNS	SEMA3C	396	Q99985
YFTLEMLHLGNNRIE	SLITRK6	386	Q9H5Y7
HTVVLTMLNFFVTEY	SAMD8	301	Q96LT4
MFSDFHGYIQNLIIR	NXPE2	501	Q96DL1
LDFSMVHYVDSRGLV	SLC26A8	726	Q96RN1
SFKIMDYSLLLGVHN	PIP5K1C	311	O60331
TLSDFAVRLGHIQYM	NBEAL2	1031	Q6ZNJ1
FKAVHTGMRALIYNS	PLEKHA7	231	Q6IQ23
YMNSVSFLEGHLDQL	PRAMEF25	276	A6NGN4
GFIYTGEVVHRMLTA	PLXDC2	181	Q6UX71
PHTYVEMQSLQIAAF	SMG9	296	Q9H0W8
VMSFYNGVRITHQEV	SETD7	241	Q8WTS6
TYGMVVADLFHSLLA	SHLD2	776	Q86V20
TSGIYHINQEIFRMF	ST8SIA5	136	O15466
AMEGETLHTFYTQLV	SCARB1	421	Q8WTV0
DMYAGAIFIQQSLHL	SLC5A11	161	Q8WWX8
DNGSAFYLHMLRVTQ	OCSTAMP	191	Q9BR26
YMNSVSFLEGHLDQL	PRAMEF27	276	A3QJZ7
IEDYNLLAGHLAMFT	WDR19	716	Q8NEZ3
HMLLLTNTFGAINYV	ITGAL	226	P20701
RQETFVYEMESHAIG	SNAPC3	151	Q92966
SALYNAIHLGQMDLS	STRA6	536	Q9BX79
RYLIHQSLAATMFEF	STARD3	416	Q14849
LGQDYEHVTMLQERF	SPTBN1	1726	Q01082
NTERGALLTTHYMAE	ABCA8	1466	O94911
GVSSIYRMILQQDFT	ACSM1	316	Q08AH1
AMNLHSGLREYTLTS	AMMECR1	181	Q9Y4X0
LYTQEVLEMGHNVSF	ANKFN1	706	Q8N957
LVMASYILSGAHQEL	CHST15	91	Q7LFX5
TVRYMFETQHLDQLG	XIRP2	516	A4UGR9
LQYFMLHETVAPSDI	SLC35G4	296	P0C7Q5
YMNSVSFLEGHLDQL	PRAMEF4	276	O60810
QRMGDTHTGLALVYA	VWA1	106	Q6PCB0
SGNFIIVLYSMTHKE	STIL	296	Q15468
SIGLMFYVVHRAQVE	TMEM64	321	Q6YI46
RVMLENYSHLVSLGF	ZFP92	41	A6NM28
YLRTMTHIVFVDFDN	ZNF451	881	Q9Y4E5
EGLSYLISFQTHIRM	ZNF700	341	Q9H0M5
SYLTAASFLQMQHII	ZBTB37	101	Q5TC79
LRGHAAEISDMAVNY	PHIP	221	Q8WWQ0
RQGSVYHSDLFAMIG	RHBG	211	Q9H310
AIAAQLENMSTGYHL	PATJ	1766	Q8NI35
MFEHLSYLLENSSVG	RYR3	2111	Q15413
YMNSVSFLEGHLDQL	PRAMEF9	276	P0DUQ2
EYRDVMLETFGHLVS	ZNF274	311	Q96GC6
YTVMFRIHAEFQLSE	SELENON	286	Q9NZV5
ALHSLTQAGDYSMRV	TNXB	4106	P22105
LRYGLALIMHFSNFT	SLC17A2	16	O00624
LYLNESGTMLRVAHL	TMEM186	131	Q96B77
DVMLENFAHVTSLGY	ZNF551	56	Q7Z340
IYHLTSFMLENGTSD	GPLD1	261	P80108
FLTVTLHQGGATRMY	GPLD1	681	P80108
IYELFSVMVHSGSAA	USP47	486	Q96K76
ETKMQEARLHSGYIF	USP29	866	Q9HBJ7
HLYFDVMLENFALTS	ZNF211	56	Q13398
YMNSVSFLEGHLDQL	PRAMEF11	276	O60813
AYLSAELFHLSGIMA	SLC9A1	341	P19634
HLSLFIVIMRGEYDA	TRAF1	321	Q13077
AFIYAVMAAGLVHSV	WNT16	121	Q9UBV4
NLHGFEVDSRVYLLM	POLR2H	131	P52434
LFHLQSVTAYALMGK	SLC35E2B	306	P0CK96
TMERLEVHSNGSVAY	ATP6AP1	341	Q15904
MLFIHFANVYLADLT	STIMATE	81	Q86TL2
VSLSIAVMDYDRVGH	SYT10	446	Q6XYQ8
QGVLTLETAYHMAVA	TNPO3	271	Q9Y5L0
QMVFGVILSLFNHIY	ATP6V0A4	551	Q9HBG4
LNTYELIHTGEMSYR	ZNF112	346	Q9UJU3
GFLLYEAVQRTIHMN	SLC30A4	196	O14863
ALTHMLYTAIAFLGV	SLC30A5	186	Q8TAD4
YHMSVELLRSVNDFL	TRAPPC9	226	Q96Q05
GQILDFMYTSHLDLN	ZBTB49	76	Q6ZSB9
IFSHIYNTILLMDGN	TMEM117	121	Q9H0C3
YNNRLAEHIVSMLFT	USP34	2576	Q70CQ2
SFIHAISSAGVMYII	WNT8A	86	Q9H1J5
VGGSHYLLMDRVSQI	UGT3A2	31	Q3SY77
VRFLHETGLAMIYGL	SLC9A7	96	Q96T83
AMLLHFLDTYQGLLQ	RAPGEFL1	221	Q9UHV5
SYIEIFGRTMQLNLS	UBR4	2366	Q5T4S7
GSALQYDTLISLMEH	UBR4	3261	Q5T4S7
LYVTRLDNVTVAHMG	MST1R	451	Q04912
YFHDQVLLKGMTSIS	ZBTB22	81	O15209
QSTMGRDLIIHFITY	VWA3A	286	A6NCI4
IMSVANRLVESGHYA	TRIO	401	O75962
VALVYTTMAEHFLTL	TSPAN1	106	O60635
LHNDGIYIMSRDVTL	KLHL42	446	Q9P2K6
RVMHAPTLQIAEYVF	NALCN	911	Q8IZF0
GDVTFHDVLSMLSYR	NALCN	1526	Q8IZF0
MYTAGFLQIQHIVER	NACC2	101	Q96BF6
LEQVQLYYSRHMGEL	MYO7B	116	Q6PIF6
GQRLLLSTMHEEYEF	MYO7B	1466	Q6PIF6
YIIESRYGMHTLEIN	MYOM1	326	P52179
LARTMNFTYEVHLVA	GRIN1	466	Q05586